LENVATINIB treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
The LENVIMA Co-pay Program is a patient support program offered by the manufacturer. Eligible commercially insured patients could pay as little as $0 out of pocket for each prescription. Enrollment is available through your healthcare provider or pharmacist. This program is not available to patients enrolled in state or federal healthcare programs, including Medicare, Medicaid, Medigap, VA, DoD, or TRICARE.
To learn more about the program, including how to enroll, please talk to your pharmacist.
Additional Terms and Conditions apply. See eligibility requirements at eisaipatientsupport.com/lenvima